Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
Stacey Ma, PhD, serves as Executive Vice President of Pharmaceutical Development and Manufacturing, with responsibility for all the company’s investigational compounds and marketed products.
Stacey joined Gilead in 2022 after more than two decades in the biopharmaceutical industry. Prior to Gilead, she served as Executive Vice President of Technical Operations at Sana Biotechnology and as Global Head of Innovation, Manufacturing Science and Technology at Genentech/Roche.
She has a PhD in chemical engineering from Yale University and master’s and bachelor’s degrees in chemical engineering from Yale and the University of Minnesota, respectively.
Stacey currently serves on the Board of Directors for Atreca, Inc., a biotechnology company.
-
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
-
Andrew Dickinson
Chief Financial Officer
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
-
Flavius Martin, MD
Executive Vice President, Research
-
Jyoti Mehra
Executive Vice President, Human Resources
-
Johanna Mercier
Chief Commercial Officer
-
Merdad Parsey, MD, PhD
Chief Medical Officer
-
Cindy Perettie
Executive Vice President, Kite
-
Deborah H. Telman
Executive Vice President, Corporate Affairs and General Counsel